JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB243878

Anti-Ki67 antibody [BLR021E]

Be the first to review this product! Submit a review

|

(27 Publications)

Rabbit Recombinant Monoclonal Ki67 antibody. Suitable for IHC-P, ICC, Flow Cyt, ICC/IF and reacts with Human samples. Cited in 27 publications. Immunogen corresponding to Synthetic Peptide within Human MKI67 aa 1200-1250.

View Alternative Names

Proliferation marker protein Ki-67, Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Antigen Ki67, MKI67

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-Ki67 antibody [BLR021E] (AB243878)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Ki67 antibody [BLR021E] (AB243878)

Immunocytochemical analysis of acetone/menthanol fixed HeLa cells, labeling Ki67 with ab243878 at a 1/100 dilution. HRP-conjugated goat anti-rabbit IgG was used as a secondary antibody. Counterstain : DAPI.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody [BLR021E] (AB243878)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody [BLR021E] (AB243878)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human tonsil tissue, labeling Ki67 with ab243878. HRP-conjugated goat anti-rabbit IgG was used as a secondary antibody. Detection : DAB.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody [BLR021E] (AB243878)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody [BLR021E] (AB243878)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human ovarian carcinoma tissue, labeling Ki67 with ab243878 at a 1/500 dilution. HRP-conjugated goat anti-rabbit IgG was used as a secondary antibody. Substrate : Opal™. Counterstain : DAPI (blue).

Immunocytochemistry - Anti-Ki67 antibody [BLR021E] (AB243878)
  • ICC

Supplier Data

Immunocytochemistry - Anti-Ki67 antibody [BLR021E] (AB243878)

Immunocytochemical analysis of formalin-fixed, paraffin-embedded OVCAR-4 cells, labeling Ki67 with ab243878. HRP-conjugated goat anti-rabbit IgG was used as a secondary antibody. Detection : DAB.

Flow Cytometry - Anti-Ki67 antibody [BLR021E] (AB243878)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-Ki67 antibody [BLR021E] (AB243878)

Flow cytometric analysis of 4% formaldehyde and permeabilized with 90% methanol MOLT-4 (Human lymphoblastic leukemia cell line) cells labelling Ki67 with ab243878 at 1μl/106 cells (Red shaded) compared with a Isotype control (unshaded). DyLight® 650-conjugated goat anti-rabbit IgG was used as the secondary antibody.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

BLR021E

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC, Flow Cyt, ICC/IF, IHC-P

applications

Immunogen

Synthetic Peptide within Human MKI67 aa 1200-1250. The exact immunogen used to generate this antibody is proprietary information.

P46013

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1/100 - 1/500", "ICC-species-notes": "<p>Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE cell sections.</p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µL for 10^6 Cells", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/500", "ICCIF-species-notes": "<p></p>" } } }

Product details

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

This product is sold under License from Bethyl Laboratories, Inc.

Properties and storage information

Form
Liquid
Purification notes
Recombinant antibody was purified from cell culture supernatant.
Storage buffer
pH: 7.8 - 8.6 Preservative: 0.09% Sodium azide Constituents: 98% Borate buffered saline, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ki67 is a nuclear protein often referred to as MKI67 with a molecular weight of approximately 345 kDa. This protein is strongly associated with cell proliferation. Scientists commonly use Ki67 staining techniques to identify and quantify proliferating cells in tissues. Ki67 is expressed in the nucleus during active cell cycle phases—G1 S G2 and M—but not in resting cells in G0 phase. It is detectable through methods such as Ki67 immunofluorescence and Ki67 flow cytometry which are important for analyzing cell division.
Biological function summary

The Ki67 protein plays an essential role in cellular proliferation processes. It does not form part of a stable complex but interacts transiently with other cell cycle-related proteins. Research indicates that Ki67 maintains the structure of the perichromosomal layer during mitosis impacting chromosome separation. It is particularly active in tissues with high cell turnover such as bone marrow and lymphoid organs.

Pathways

Ki67 influences several key cellular pathways that control cell proliferation and differentiation. The protein acts within the regulation of the cell cycle and the PI3K/AKT signaling pathway important for cell growth and survival. Within these pathways Ki67 interacts with proteins like cyclin-dependent kinases (CDKs) which regulate transitions between different phases of the cell cycle.

Ki67 has significant implications in oncology and can be used as a biomarker for cancer prognosis. Its expression levels help determine the aggressiveness of tumors especially in breast cancer and prostate cancer. High Ki67 levels correlate with poor prognosis as it indicates rapid cell division. In cancer Ki67 associates with p53 a protein that regulates the cell cycle and function as a tumor suppressor.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein that associates with the surface of mitotic chromosomes and acts both as a chromosome repellent during early mitosis and chromosome attractant during late mitosis (PubMed : 27362226, PubMed : 32879492, PubMed : 35513709, PubMed : 39153474). Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed : 27362226). During early mitosis, relocalizes from nucleoli to the chromosome surface where it forms extended brush structures that cover a substantial fraction of the chromosome surface (PubMed : 27362226). The MKI67 brush structure prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier : the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed : 27362226). During mitotic anaphase, the MKI67 brush structure collapses and MKI67 switches from a chromosome repellent to a chromosome attractant to promote chromosome clustering and facilitate the exclusion of large cytoplasmic particles from the future nuclear space (PubMed : 32879492, PubMed : 39153474). Mechanistically, dephosphorylation during mitotic exit and simultaneous exposure of a conserved basic patch induce the RNA-dependent formation of a liquid-like condensed phase on the chromosome surface, promoting coalescence of neighboring chromosome surfaces and clustering of chromosomes (PubMed : 39153474). Binds premature ribosomal RNAs during anaphase; promoting liquid-liquid phase separation (PubMed : 28935370, PubMed : 39153474). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (PubMed : 10878551). Does not contribute to the internal structure of mitotic chromosomes (By similarity). May play a role in chromatin organization; it is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in mitotic chromosome (PubMed : 24867636).
See full target information MKI67

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in cell and developmental biology 12:1510264 PubMed39830210

2025

Establishment and characterization of a sigmoid colon cancer organoid with spinal metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Jingyao Chen,Shumin Cheng,Liang Gu,Zhangsen Huang,Changhua Zhang,Chunhui Sun,Songyao Chen

Molecular carcinogenesis 64:552-564 PubMed39763297

2025

A-to-I-Edited miR-1304-3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Chen,Hang Zhou,Xian Yang,Yuzhen Zheng,Yujie Chen,Peiyuan Wang,Hao He,Shuoyan Liu,Feng Wang

Scientific reports 14:25120 PubMed39448672

2024

Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hongtao Fu,Shanshan Dong,Kun Li

Cancer cell international 24:220 PubMed38926706

2024

Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution.

Applications

Unspecified application

Species

Unspecified reactive species

Serena Mazzucchelli,Lorena Signati,Letizia Messa,Alma Franceschini,Arianna Bonizzi,Lorenzo Castagnoli,Patrizia Gasparini,Clarissa Consolandi,Eleonora Mangano,Paride Pelucchi,Ingrid Cifola,Tania Camboni,Marco Severgnini,Laura Villani,Barbara Tagliaferri,Stephana Carelli,Serenella M Pupa,Cristina Cereda,Fabio Corsi

Neoplasma 71:209-218 PubMed38764295

2024

Downregulation of WNK4 expression facilitates the proliferation of gastric cancer cells via activation of the STAT3 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Miao Li,Xiaoyan Shao,Qiqi Ning,Rongrong Sun,Rantian Li,Yanhua Liu,Yuan Yuan,Youwei Zhang

Annals of gastroenterological surgery 8:507-520 PubMed38707229

2024

Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p/PD-L1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chengyun Dou,Hongbo Zhu,Xia Xie,Cuiqin Huang,Hui Tan,Chuangjie Cao

Neoplasma 70:777-786 PubMed38247333

2024

CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xinlin Yang,Miao Zhang,Wei Xia,Zhongchao Mai,Ying Ye,Bin Zhao,Yanan Song

European journal of histochemistry : EJH 67: PubMed37700733

2023

Crocin exerts anti-tumor effect in colon cancer cells <em>via</em> repressing the JAK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Yang,Yunlong Zhang,Desheng Zhang,Liping Qian,Tianxing Yang,Xiaocheng Wu

Thoracic cancer 14:1606-1617 PubMed37105940

2023

Propofol mediates non-small cell lung cancer growth in part by regulating circ_0003028-related mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuli Zhang,Dongzhi Liu,Ping Wang,Naihe Liu

Open medicine (Warsaw, Poland) 18:20220539 PubMed36760719

2023

Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Lihui Zhang,Yunli Gao,Yue Li,Xinying Li,Haixia Gong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com